The tolerability profile of prophylactic norfloxacin in neutropenic patients.

Abstract

Norfloxacin has been compared to placebo (136 patients), sulfamethoxazole plus trimethoprim (SXT, 72 patients) and oral vancomycin plus colistin (V/C, 61 patients) for the prevention of alimentary tract-associated infections during and after induction chemotherapy. These patients were evaluated for the safety and tolerability of each regimen by clinical and… (More)

Topics

  • Presentations referencing similar topics